Now I have all the information I need. Let me write the final consolidated review.

## Calibration Analysis

**Round 1 Bracket (by score band):**
- Strong reject (< 2.5): Papers like "TCIG" (1.50) — not relevant; our paper is clearly better.
- Weak (2.5–4.5): "Reducing Atomic Clashes" (3.75) has similar plug-in correction idea for molecular diffusion and similar issues (missing implementation details, ad-hoc choices), but DIST has much stronger theoretical framing, larger-scale experiments (3 backbones vs. 1), and clearer problem diagnosis. DIST is significantly better.
- Middle-low (4.5–6.1): "MoreRed" (4.75) has weak baselines and limited evaluation; "EQGAT-diff" (5.75) has strong experiments but limited novelty; "Dynamics-Informed Protein Design" (5.50). DIST is comparable or slightly better than these.
- Middle-high (6.0–7.5): "Bias Mitigation in Graph Diffusion" (6.50) is very clean — minimal weaknesses, extensive experiments; "Lift Your Molecules" (6.50); "TFG-Flow" (6.25); "Megalodon" (6.33). DIST has stronger theory than these but noticeably weaker experimental rigor (baselines not re-run, missing std devs, method underspecified).
- Strong (>7.5): "GeoBFN" (8.00) — clearly stronger across all dimensions.

**Round 2 Narrowing:**
Reading full reviews of anchors in 4.5–6.0 and 6.0–7.5 ranges confirms that DIST sits between the "clean experiment but limited novelty" papers (~5.75) and the "strong theory but experimental holes" papers. Compared to EQGAT-diff (5.75), DIST has stronger theory but weaker evaluation; compared to MoreRed (4.75), DIST is clearly better on all fronts. The paper has genuine theoretical contribution but the evaluation concerns (baselines not re-run, method underspecified, missing std devs) prevent it from reaching the 6+ tier.

**Final Score: 5.5**

---

## Summary

This paper identifies that molecular data distributions have "dense-concentrated structure" (DC-structure) — narrowly peaked and densely packed — which causes diffusion model trajectories to overshoot valid regions and drift into invalid states. The authors formalize this structure (Definition 3.1), analyze error propagation (Eq. 6–7), and propose **DIST**, a plug-in corrective sampling method that evaluates intermediate model distributions via pilot reverse runs, filters out deviant batches, and steers trajectories back toward valid molecular peaks. Experiments on QM9 and GEOM-Drugs with EDM, GeoLDM, and RADM backbones show consistent improvements in stability and validity while roughly halving the required inference timesteps.

## Strengths

- **Formal mathematical characterization of DC-structure (Definition 3.1):** The paper provides a precise probabilistic definition — a mixture of narrow Gaussians with bounded covariance, well-separated peaks, and concentration guarantees — that cleanly captures the intuition about molecular distributions. This directly leads to the overshoot condition in Eq. 7, which provides a concrete mechanistic explanation for why molecular diffusion fails.

- **Theoretical guarantees for corrective sampling (Corollary 3.1 + Proposition 3.1):** Corollary 3.1 proves a TV-contraction bound showing that steering the intermediate distribution toward the true marginal reduces the final distribution gap. Proposition 3.1 provides an explicit error bound for the selectively corrected distribution, giving a principled reason for why filtering should work.

- **Consistent improvements across three distinct backbones and two datasets (Table 2):** DIST improves EDM, GeoLDM, and RADM on both QM9 and GEOM-Drugs across every metric. On QM9, Mol Sta improves from 82.0%→89.9% (EDM), 89.4%→93.4% (GeoLDM), 87.3%→91.4% (RADM). Gains hold across GNN-based equivariant, latent-space, and Transformer-based non-equivariant architectures, demonstrating genuine model-agnosticism.

- **Diagnostic experiment isolating error accumulation (Table 1):** Running reverse inference from progressively noisier inputs shows Mol Sta declining monotonically from 95.2% (t=0) to 82.0% (t=1000), providing direct empirical evidence that errors compound across timesteps. This makes the problem diagnosis independently testable.

- **Clean ablation on pilot subset size (Table 4):** Varying pilot sizes (30, 50, 100) shows monotonic improvement in all metrics together with monotonic timestep cost, confirming the mechanism operates as intended.

## Weaknesses

### Fatal
None.

### Major
None.

### Minor

1. **Key implementation details deferred to appendix, making the method underspecified in the main text.** The main text does not specify which pilot score \(s_j\) is actually used — only listing vague possibilities ("round-trip residual, self-consistency, ensemble variance, or chemistry-based penalty," line 150). The threshold \(\tau\) selection, batch construction details (perturbation radius \(r\)), and the exact intermediate timestep \(t\) are similarly unspecified. While the appendix likely contains these in the original submission, readers assessing the main text cannot evaluate the concrete algorithm that was actually run, and the experimental results cannot be properly interpreted without knowing these choices.

2. **Baseline results taken from original papers rather than re-run in a controlled setting.** The paper states "The results of backbone models and baseline methods are directly obtained from their original work" (line 205). This means the comparison in Table 2 mixes results from potentially different random seeds, evaluation protocols, or dataset splits. While DIST is evaluated using official weights, the backbone numbers may come from different procedures, weakening the claim of controlled comparison that is the standard for empirical papers claiming improvement.

3. **Efficiency accounting in the main text is simplified and could mislead.** The formula in Sec. 4.3 — \((T-t)/|B| + t\) — describes the amortized cost for the T→t segment and the t→0 segment but does not explicitly account for the computational cost of running the pilot subset inference. The empirical timestep numbers in Tables 3 and 4 are real measurements that include all costs, so the overall efficiency claim (halving timesteps) is supported. However, the simplified formula gives an incomplete picture and could mislead readers who do not consult the appendix.

4. **No standard deviations reported for GEOM-Drugs results.** QM9 results include three-run averages with standard deviations, but GEOM-Drugs results are reported as point estimates without error bars (Table 2), making it unclear how stable the improvements are on the larger, more complex dataset.

5. **Overclaiming from limited evidence.** The paper asserts that "performance cannot be guaranteed solely by architectural choices" (line 76) based on testing only three backbone families. This is too small a set to support such a sweeping claim about all architectural approaches to molecular diffusion.

6. **Gap between DIST results and the clean-data upper bound unacknowledged.** Table 1 shows that clean data (t=0) achieves Mol Sta 95.2%, while the best DIST result (EDM+DIST) reaches only 89.9%. The paper does not acknowledge this remaining gap, which suggests substantial room for further improvement beyond what DIST currently achieves.

### Trivial
None.

## Nice-to-Haves

- A comparison against simpler baselines (e.g., multiple independent runs + majority filtering, rejection sampling on final molecules) would clarify whether DIST's gains come from its specific corrective mechanism or simply from oversampling and selection.
- Comparison against existing corrective/guidance methods for molecular generation (cited in Appendix B but not experimentally compared) would help contextualize DIST's contribution.

## Removed Points

These points were identified by reviewers but removed or downgraded for the reasons stated:

- **"Theory does not derive the method" (Harsh Critic):** Removed. Theory motivating rather than fully deriving a method is standard practice. The DC-structure analysis genuinely motivates why correction is needed, and the TV-contraction bound gives a principled reason for the filtering approach. The gap between theoretical framework and concrete implementation choices is not a weakness of the paper's theoretical contribution.

- **"Fair evaluation protocol" (Strength Finder):** Partially removed because it conflicts with verified Weakness #2 above. The paper does use official weights for DIST experiments, but the backbone-only results come from original papers, creating a mixed picture.

- **"Efficiency claim is internally inconsistent / numbers are wrong" (Harsh Critic):** Downgraded from fatal to minor. The critic's claim that efficiency numbers "are simply wrong" is incorrect — the empirical measurements in Tables 3 and 4 are real and support the claim. The formula incompleteness is a genuine clarity concern (retained as Minor #3), but not a fatal error.

- **"Table 3 variance across backbones unexplained":** Removed. Different backbones naturally accept different numbers of batches at the threshold, leading to different timestep counts.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

1. Move the specific choice of pilot score \(s_j\), threshold \(\tau\), and batch construction details (radius \(r\), perturbation method) into the main text or a dedicated algorithm box, since these are essential to understanding the method.
2. Clarify the efficiency formula to include pilot costs, or explicitly state the fraction of total cost attributable to the pilot vs. the main inference path.
3. Re-run baselines in the same evaluation pipeline as DIST, or at least provide a detailed side-by-side comparison of evaluation conditions.
4. Add standard deviations to GEOM-Drugs results.
5. Acknowledge the remaining gap to clean-data upper bounds and discuss what types of errors DIST does not address.

## Score and Decision

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Reject</decision>